nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.0219	0.0219	CcSEcCtD
Gadoteridol—Stupor—Progesterone—uterine cancer	0.0208	0.0208	CcSEcCtD
Gadoteridol—Laryngospasm—Medroxyprogesterone Acetate—uterine cancer	0.0188	0.0188	CcSEcCtD
Gadoteridol—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.0172	0.0172	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Progesterone—uterine cancer	0.015	0.015	CcSEcCtD
Gadoteridol—Fluid retention—Progesterone—uterine cancer	0.0147	0.0147	CcSEcCtD
Gadoteridol—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.014	0.014	CcSEcCtD
Gadoteridol—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.0134	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Progesterone—uterine cancer	0.0116	0.0116	CcSEcCtD
Gadoteridol—Cyanosis—Etoposide—uterine cancer	0.0112	0.0112	CcSEcCtD
Gadoteridol—Face oedema—Progesterone—uterine cancer	0.0109	0.0109	CcSEcCtD
Gadoteridol—Laryngospasm—Etoposide—uterine cancer	0.0106	0.0106	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.0106	0.0106	CcSEcCtD
Gadoteridol—Tingling sensation—Etoposide—uterine cancer	0.00988	0.00988	CcSEcCtD
Gadoteridol—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.00986	0.00986	CcSEcCtD
Gadoteridol—Dysphagia—Progesterone—uterine cancer	0.00974	0.00974	CcSEcCtD
Gadoteridol—Apnoea—Etoposide—uterine cancer	0.00937	0.00937	CcSEcCtD
Gadoteridol—Cardiovascular disorder—Etoposide—uterine cancer	0.00904	0.00904	CcSEcCtD
Gadoteridol—Pain—Carboplatin—uterine cancer	0.00902	0.00902	CcSEcCtD
Gadoteridol—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00883	0.00883	CcSEcCtD
Gadoteridol—Body temperature increased—Carboplatin—uterine cancer	0.00834	0.00834	CcSEcCtD
Gadoteridol—Rhinitis—Progesterone—uterine cancer	0.00782	0.00782	CcSEcCtD
Gadoteridol—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00755	0.00755	CcSEcCtD
Gadoteridol—Generalised oedema—Epirubicin—uterine cancer	0.00749	0.00749	CcSEcCtD
Gadoteridol—Tinnitus—Progesterone—uterine cancer	0.00727	0.00727	CcSEcCtD
Gadoteridol—Rash maculo-papular—Etoposide—uterine cancer	0.00722	0.00722	CcSEcCtD
Gadoteridol—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00719	0.00719	CcSEcCtD
Gadoteridol—Generalised oedema—Doxorubicin—uterine cancer	0.00693	0.00693	CcSEcCtD
Gadoteridol—Dysphagia—Dactinomycin—uterine cancer	0.00689	0.00689	CcSEcCtD
Gadoteridol—Erythema—Progesterone—uterine cancer	0.00679	0.00679	CcSEcCtD
Gadoteridol—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00659	0.00659	CcSEcCtD
Gadoteridol—Tremor—Progesterone—uterine cancer	0.00636	0.00636	CcSEcCtD
Gadoteridol—Ill-defined disorder—Progesterone—uterine cancer	0.0063	0.0063	CcSEcCtD
Gadoteridol—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00615	0.00615	CcSEcCtD
Gadoteridol—Malaise—Progesterone—uterine cancer	0.00612	0.00612	CcSEcCtD
Gadoteridol—Syncope—Progesterone—uterine cancer	0.00609	0.00609	CcSEcCtD
Gadoteridol—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00602	0.00602	CcSEcCtD
Gadoteridol—Loss of consciousness—Progesterone—uterine cancer	0.00597	0.00597	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Etoposide—uterine cancer	0.00596	0.00596	CcSEcCtD
Gadoteridol—Cough—Progesterone—uterine cancer	0.00592	0.00592	CcSEcCtD
Gadoteridol—Convulsion—Progesterone—uterine cancer	0.00588	0.00588	CcSEcCtD
Gadoteridol—Hypertension—Progesterone—uterine cancer	0.00586	0.00586	CcSEcCtD
Gadoteridol—Chest pain—Progesterone—uterine cancer	0.00578	0.00578	CcSEcCtD
Gadoteridol—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00576	0.00576	CcSEcCtD
Gadoteridol—Anxiety—Progesterone—uterine cancer	0.00576	0.00576	CcSEcCtD
Gadoteridol—Discomfort—Progesterone—uterine cancer	0.00571	0.00571	CcSEcCtD
Gadoteridol—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00571	0.00571	CcSEcCtD
Gadoteridol—Gingivitis—Epirubicin—uterine cancer	0.00567	0.00567	CcSEcCtD
Gadoteridol—Dry mouth—Progesterone—uterine cancer	0.00565	0.00565	CcSEcCtD
Gadoteridol—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00555	0.00555	CcSEcCtD
Gadoteridol—Oedema—Progesterone—uterine cancer	0.00554	0.00554	CcSEcCtD
Gadoteridol—Anaphylactic shock—Progesterone—uterine cancer	0.00554	0.00554	CcSEcCtD
Gadoteridol—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00552	0.00552	CcSEcCtD
Gadoteridol—Cardiac arrest—Etoposide—uterine cancer	0.00548	0.00548	CcSEcCtD
Gadoteridol—Injection site pain—Epirubicin—uterine cancer	0.00545	0.00545	CcSEcCtD
Gadoteridol—Shock—Progesterone—uterine cancer	0.00545	0.00545	CcSEcCtD
Gadoteridol—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00541	0.00541	CcSEcCtD
Gadoteridol—Hyperhidrosis—Progesterone—uterine cancer	0.00536	0.00536	CcSEcCtD
Gadoteridol—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00533	0.00533	CcSEcCtD
Gadoteridol—Gingivitis—Doxorubicin—uterine cancer	0.00525	0.00525	CcSEcCtD
Gadoteridol—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00524	0.00524	CcSEcCtD
Gadoteridol—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00522	0.00522	CcSEcCtD
Gadoteridol—Hypotension—Progesterone—uterine cancer	0.00518	0.00518	CcSEcCtD
Gadoteridol—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00517	0.00517	CcSEcCtD
Gadoteridol—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00512	0.00512	CcSEcCtD
Gadoteridol—Flushing—Dactinomycin—uterine cancer	0.00512	0.00512	CcSEcCtD
Gadoteridol—Cardiovascular disorder—Epirubicin—uterine cancer	0.00507	0.00507	CcSEcCtD
Gadoteridol—Injection site pain—Doxorubicin—uterine cancer	0.00505	0.00505	CcSEcCtD
Gadoteridol—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00502	0.00502	CcSEcCtD
Gadoteridol—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00502	0.00502	CcSEcCtD
Gadoteridol—Dysphagia—Etoposide—uterine cancer	0.00498	0.00498	CcSEcCtD
Gadoteridol—Paraesthesia—Progesterone—uterine cancer	0.00498	0.00498	CcSEcCtD
Gadoteridol—Dyspnoea—Progesterone—uterine cancer	0.00494	0.00494	CcSEcCtD
Gadoteridol—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00494	0.00494	CcSEcCtD
Gadoteridol—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.00485	CcSEcCtD
Gadoteridol—Lacrimation increased—Epirubicin—uterine cancer	0.00483	0.00483	CcSEcCtD
Gadoteridol—Erythema—Dactinomycin—uterine cancer	0.0048	0.0048	CcSEcCtD
Gadoteridol—Pain—Progesterone—uterine cancer	0.00474	0.00474	CcSEcCtD
Gadoteridol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00469	0.00469	CcSEcCtD
Gadoteridol—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00469	0.00469	CcSEcCtD
Gadoteridol—Feeling abnormal—Progesterone—uterine cancer	0.00457	0.00457	CcSEcCtD
Gadoteridol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00451	0.00451	CcSEcCtD
Gadoteridol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00448	0.00448	CcSEcCtD
Gadoteridol—Lacrimation increased—Doxorubicin—uterine cancer	0.00447	0.00447	CcSEcCtD
Gadoteridol—Ill-defined disorder—Dactinomycin—uterine cancer	0.00445	0.00445	CcSEcCtD
Gadoteridol—Injection site reaction—Epirubicin—uterine cancer	0.00443	0.00443	CcSEcCtD
Gadoteridol—Urticaria—Progesterone—uterine cancer	0.0044	0.0044	CcSEcCtD
Gadoteridol—Abdominal pain—Progesterone—uterine cancer	0.00438	0.00438	CcSEcCtD
Gadoteridol—Body temperature increased—Progesterone—uterine cancer	0.00438	0.00438	CcSEcCtD
Gadoteridol—Malaise—Dactinomycin—uterine cancer	0.00433	0.00433	CcSEcCtD
Gadoteridol—Salivary hypersecretion—Epirubicin—uterine cancer	0.00432	0.00432	CcSEcCtD
Gadoteridol—Fluid retention—Epirubicin—uterine cancer	0.00423	0.00423	CcSEcCtD
Gadoteridol—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00414	0.00414	CcSEcCtD
Gadoteridol—Injection site reaction—Doxorubicin—uterine cancer	0.0041	0.0041	CcSEcCtD
Gadoteridol—Hypersensitivity—Progesterone—uterine cancer	0.00408	0.00408	CcSEcCtD
Gadoteridol—Rash maculo-papular—Epirubicin—uterine cancer	0.00405	0.00405	CcSEcCtD
Gadoteridol—Discomfort—Dactinomycin—uterine cancer	0.00404	0.00404	CcSEcCtD
Gadoteridol—Salivary hypersecretion—Doxorubicin—uterine cancer	0.004	0.004	CcSEcCtD
Gadoteridol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00399	0.00399	CcSEcCtD
Gadoteridol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00397	0.00397	CcSEcCtD
Gadoteridol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00397	0.00397	CcSEcCtD
Gadoteridol—Pruritus—Progesterone—uterine cancer	0.00392	0.00392	CcSEcCtD
Gadoteridol—Oedema—Dactinomycin—uterine cancer	0.00392	0.00392	CcSEcCtD
Gadoteridol—Fluid retention—Doxorubicin—uterine cancer	0.00391	0.00391	CcSEcCtD
Gadoteridol—Diarrhoea—Progesterone—uterine cancer	0.00379	0.00379	CcSEcCtD
Gadoteridol—Rash maculo-papular—Doxorubicin—uterine cancer	0.00375	0.00375	CcSEcCtD
Gadoteridol—Flushing—Etoposide—uterine cancer	0.0037	0.0037	CcSEcCtD
Gadoteridol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0037	0.0037	CcSEcCtD
Gadoteridol—Dizziness—Progesterone—uterine cancer	0.00366	0.00366	CcSEcCtD
Gadoteridol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.00355	CcSEcCtD
Gadoteridol—Vomiting—Progesterone—uterine cancer	0.00352	0.00352	CcSEcCtD
Gadoteridol—Rash—Progesterone—uterine cancer	0.00349	0.00349	CcSEcCtD
Gadoteridol—Dermatitis—Progesterone—uterine cancer	0.00349	0.00349	CcSEcCtD
Gadoteridol—Headache—Progesterone—uterine cancer	0.00347	0.00347	CcSEcCtD
Gadoteridol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.00344	CcSEcCtD
Gadoteridol—Dysgeusia—Etoposide—uterine cancer	0.0034	0.0034	CcSEcCtD
Gadoteridol—Pain—Dactinomycin—uterine cancer	0.00335	0.00335	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00334	0.00334	CcSEcCtD
Gadoteridol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00332	CcSEcCtD
Gadoteridol—Nausea—Progesterone—uterine cancer	0.00329	0.00329	CcSEcCtD
Gadoteridol—Feeling abnormal—Dactinomycin—uterine cancer	0.00323	0.00323	CcSEcCtD
Gadoteridol—Ill-defined disorder—Etoposide—uterine cancer	0.00322	0.00322	CcSEcCtD
Gadoteridol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.00319	CcSEcCtD
Gadoteridol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00317	0.00317	CcSEcCtD
Gadoteridol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00316	CcSEcCtD
Gadoteridol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00315	0.00315	CcSEcCtD
Gadoteridol—Malaise—Etoposide—uterine cancer	0.00313	0.00313	CcSEcCtD
Gadoteridol—Face oedema—Epirubicin—uterine cancer	0.00312	0.00312	CcSEcCtD
Gadoteridol—Abdominal pain—Dactinomycin—uterine cancer	0.0031	0.0031	CcSEcCtD
Gadoteridol—Body temperature increased—Dactinomycin—uterine cancer	0.0031	0.0031	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00309	0.00309	CcSEcCtD
Gadoteridol—Cardiac arrest—Epirubicin—uterine cancer	0.00307	0.00307	CcSEcCtD
Gadoteridol—Loss of consciousness—Etoposide—uterine cancer	0.00305	0.00305	CcSEcCtD
Gadoteridol—Cough—Etoposide—uterine cancer	0.00303	0.00303	CcSEcCtD
Gadoteridol—Convulsion—Etoposide—uterine cancer	0.00301	0.00301	CcSEcCtD
Gadoteridol—Hypertension—Etoposide—uterine cancer	0.003	0.003	CcSEcCtD
Gadoteridol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.00298	CcSEcCtD
Gadoteridol—Chest pain—Etoposide—uterine cancer	0.00296	0.00296	CcSEcCtD
Gadoteridol—Discomfort—Etoposide—uterine cancer	0.00292	0.00292	CcSEcCtD
Gadoteridol—Face oedema—Doxorubicin—uterine cancer	0.00289	0.00289	CcSEcCtD
Gadoteridol—Hypersensitivity—Dactinomycin—uterine cancer	0.00289	0.00289	CcSEcCtD
Gadoteridol—Cardiac arrest—Doxorubicin—uterine cancer	0.00284	0.00284	CcSEcCtD
Gadoteridol—Anaphylactic shock—Etoposide—uterine cancer	0.00283	0.00283	CcSEcCtD
Gadoteridol—Dysphagia—Epirubicin—uterine cancer	0.00279	0.00279	CcSEcCtD
Gadoteridol—Hyperhidrosis—Etoposide—uterine cancer	0.00274	0.00274	CcSEcCtD
Gadoteridol—Diarrhoea—Dactinomycin—uterine cancer	0.00268	0.00268	CcSEcCtD
Gadoteridol—Hypotension—Etoposide—uterine cancer	0.00265	0.00265	CcSEcCtD
Gadoteridol—Dysphagia—Doxorubicin—uterine cancer	0.00259	0.00259	CcSEcCtD
Gadoteridol—Paraesthesia—Etoposide—uterine cancer	0.00255	0.00255	CcSEcCtD
Gadoteridol—Dyspnoea—Etoposide—uterine cancer	0.00253	0.00253	CcSEcCtD
Gadoteridol—Vomiting—Dactinomycin—uterine cancer	0.00249	0.00249	CcSEcCtD
Gadoteridol—Rash—Dactinomycin—uterine cancer	0.00247	0.00247	CcSEcCtD
Gadoteridol—Pain—Etoposide—uterine cancer	0.00242	0.00242	CcSEcCtD
Gadoteridol—Sweating—Epirubicin—uterine cancer	0.00239	0.00239	CcSEcCtD
Gadoteridol—Feeling abnormal—Etoposide—uterine cancer	0.00234	0.00234	CcSEcCtD
Gadoteridol—Nausea—Dactinomycin—uterine cancer	0.00233	0.00233	CcSEcCtD
Gadoteridol—Bradycardia—Epirubicin—uterine cancer	0.00228	0.00228	CcSEcCtD
Gadoteridol—Urticaria—Etoposide—uterine cancer	0.00225	0.00225	CcSEcCtD
Gadoteridol—Rhinitis—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Gadoteridol—Abdominal pain—Etoposide—uterine cancer	0.00224	0.00224	CcSEcCtD
Gadoteridol—Body temperature increased—Etoposide—uterine cancer	0.00224	0.00224	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—uterine cancer	0.00221	0.00221	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—uterine cancer	0.00211	0.00211	CcSEcCtD
Gadoteridol—Hypersensitivity—Etoposide—uterine cancer	0.00209	0.00209	CcSEcCtD
Gadoteridol—Tinnitus—Epirubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Gadoteridol—Flushing—Epirubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Gadoteridol—Pruritus—Etoposide—uterine cancer	0.00201	0.00201	CcSEcCtD
Gadoteridol—Erythema—Epirubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Gadoteridol—Diarrhoea—Etoposide—uterine cancer	0.00194	0.00194	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—uterine cancer	0.00193	0.00193	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Gadoteridol—Dysgeusia—Epirubicin—uterine cancer	0.00191	0.00191	CcSEcCtD
Gadoteridol—Dizziness—Etoposide—uterine cancer	0.00187	0.00187	CcSEcCtD
Gadoteridol—Ill-defined disorder—Epirubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Gadoteridol—Vomiting—Etoposide—uterine cancer	0.0018	0.0018	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Gadoteridol—Rash—Etoposide—uterine cancer	0.00179	0.00179	CcSEcCtD
Gadoteridol—Dermatitis—Etoposide—uterine cancer	0.00179	0.00179	CcSEcCtD
Gadoteridol—Headache—Etoposide—uterine cancer	0.00178	0.00178	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—uterine cancer	0.00176	0.00176	CcSEcCtD
Gadoteridol—Malaise—Epirubicin—uterine cancer	0.00176	0.00176	CcSEcCtD
Gadoteridol—Syncope—Epirubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Gadoteridol—Loss of consciousness—Epirubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Gadoteridol—Cough—Epirubicin—uterine cancer	0.0017	0.0017	CcSEcCtD
Gadoteridol—Convulsion—Epirubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Gadoteridol—Nausea—Etoposide—uterine cancer	0.00168	0.00168	CcSEcCtD
Gadoteridol—Hypertension—Epirubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—uterine cancer	0.00167	0.00167	CcSEcCtD
Gadoteridol—Chest pain—Epirubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Gadoteridol—Anxiety—Epirubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Gadoteridol—Discomfort—Epirubicin—uterine cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Gadoteridol—Dry mouth—Epirubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Gadoteridol—Oedema—Epirubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Anaphylactic shock—Epirubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Gadoteridol—Shock—Epirubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—uterine cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Hyperhidrosis—Epirubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Hypotension—Epirubicin—uterine cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Gadoteridol—Paraesthesia—Epirubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Dyspnoea—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Pain—Epirubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Gadoteridol—Feeling abnormal—Epirubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Gadoteridol—Urticaria—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Gadoteridol—Abdominal pain—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Gadoteridol—Body temperature increased—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Hypersensitivity—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Gadoteridol—Pruritus—Epirubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Gadoteridol—Diarrhoea—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Gadoteridol—Dizziness—Epirubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Vomiting—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Gadoteridol—Rash—Epirubicin—uterine cancer	0.001	0.001	CcSEcCtD
Gadoteridol—Dermatitis—Epirubicin—uterine cancer	0.001	0.001	CcSEcCtD
Gadoteridol—Headache—Epirubicin—uterine cancer	0.000995	0.000995	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—uterine cancer	0.000972	0.000972	CcSEcCtD
Gadoteridol—Nausea—Epirubicin—uterine cancer	0.000944	0.000944	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—uterine cancer	0.000935	0.000935	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—uterine cancer	0.000927	0.000927	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—uterine cancer	0.000926	0.000926	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—uterine cancer	0.000921	0.000921	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—uterine cancer	0.000873	0.000873	CcSEcCtD
